Talk:Mavrilimumab

External links modified
Hello fellow Wikipedians,

I have just modified one external link on Mavrilimumab. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
 * Added archive https://web.archive.org/web/20120928202943/http://www.ama-assn.org/resources/doc/usan/mavrilimumab.pdf to http://www.ama-assn.org/resources/doc/usan/mavrilimumab.pdf

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

Cheers.— InternetArchiveBot  (Report bug) 04:23, 23 March 2017 (UTC)

2018 update
Three year phase II results for RA published in 2018 : [https://www.healio.com/rheumatology/rheumatoid-arthritis/news/online/%7B30f6c562-1ccf-4ce1-9ada-da05e45079a4%7D/mavrilimumab-well-tolerated-among-patients-with-ra Mavrilimumab well tolerated among patients with RA. Feb 2018]. No phase 3 studies registered yet. - Rod57 (talk) 13:18, 27 February 2018 (UTC)